Literature DB >> 15010814

Microarray profiling of the effects of histone deacetylase inhibitors on gene expression in cancer cell lines.

S G Gray1, C-N Qian, K Furge, X Guo, B T Teh.   

Abstract

Chromatin is a highly dynamic environment playing critical roles in the regulation of gene expression. Modifications to the proteins which make up the nucleosome core have been shown to have profound regulatory effects on gene expression. Of these, the best known modification is acetylation of the histone tails. Two enzymes regulate these processes, histone deacetylases and histone acetyltransferases. Both have been shown to have dysregulated functions in certain tumors. Several classes of histone deacetylase inhibitors have been isolated and are currently undergoing evaluation as potential therapeutic modalities in the treatment of cancer. In this study we examined the effects of three such inhibitors on general gene expression in three tumor cell lines derived from three separate tumor types using microarray gene profiling. Our results show that the patterns of alterations which emerge are similar for each cell type.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15010814     DOI: 10.3892/ijo.24.4.773

Source DB:  PubMed          Journal:  Int J Oncol        ISSN: 1019-6439            Impact factor:   5.650


  33 in total

1.  Use of mouse hematopoietic stem and progenitor cells to treat acute kidney injury.

Authors:  Ling Li; Rachel Black; Zhendong Ma; Qiwen Yang; Andrew Wang; Fangming Lin
Journal:  Am J Physiol Renal Physiol       Date:  2011-09-21

Review 2.  Genetics of hepatocellular carcinoma.

Authors:  Andreas Teufel; Frank Staib; Stephan Kanzler; Arndt Weinmann; Henning Schulze-Bergkamen; Peter-R Galle
Journal:  World J Gastroenterol       Date:  2007-04-28       Impact factor: 5.742

3.  Overexpression of asparagine synthetase and matrix metalloproteinase 19 confers cisplatin sensitivity in nasopharyngeal carcinoma cells.

Authors:  Ran-Yi Liu; Zizheng Dong; Jianguo Liu; Ling Zhou; Wenlin Huang; Sok Kean Khoo; Zhongfa Zhang; David Petillo; Bin Tean Teh; Chao-Nan Qian; Jian-Ting Zhang
Journal:  Mol Cancer Ther       Date:  2013-08-16       Impact factor: 6.261

Review 4.  Molecular epigenetics and genetics in neuro-oncology.

Authors:  Raman P Nagarajan; Joseph F Costello
Journal:  Neurotherapeutics       Date:  2009-07       Impact factor: 7.620

Review 5.  Histone deacetylase inhibitors: a chemical genetics approach to understanding cellular functions.

Authors:  Paul A Marks
Journal:  Biochim Biophys Acta       Date:  2010-06-08

Review 6.  Histone deacetylases and their inhibitors in cancer, neurological diseases and immune disorders.

Authors:  Katrina J Falkenberg; Ricky W Johnstone
Journal:  Nat Rev Drug Discov       Date:  2014-08-18       Impact factor: 84.694

7.  Proteomic analysis of cervical cancer cells treated with suberonylanilide hydroxamic acid.

Authors:  Jianxiong He; Canhua Huang; Aiping Tong; Bin Chen; Zhi Zeng; Peng Zhang; Chunting Wang; Yuquan Wei
Journal:  J Biosci       Date:  2008-12       Impact factor: 1.826

8.  Yin Yang 1 is a repressor of glutamate transporter EAAT2, and it mediates manganese-induced decrease of EAAT2 expression in astrocytes.

Authors:  Pratap Karki; Anton Webb; Keisha Smith; James Johnson; Kyuwon Lee; Deok-Soo Son; Michael Aschner; Eunsook Lee
Journal:  Mol Cell Biol       Date:  2014-01-27       Impact factor: 4.272

Review 9.  TRAIL gene therapy: from preclinical development to clinical application.

Authors:  Thomas S Griffith; Brittany Stokes; Tamara A Kucaba; James K Earel; Rebecca L VanOosten; Erik L Brincks; Lyse A Norian
Journal:  Curr Gene Ther       Date:  2009-02       Impact factor: 4.391

10.  Gene expression profiling of KBH-A42, a novel histone deacetylase inhibitor, in human leukemia and bladder cancer cell lines.

Authors:  Moo Rim Kang; Jong Soon Kang; Jeong Wook Yang; Bo Geun Kim; Jin-Ah Kim; Yeong Nang Jo; Kiho Lee; Chang Woo Lee; Ki Hoon Lee; Jieun Yun; Hwan Mook Kim; Gyoonhee Han; Jong Seong Kang; Song-Kyu Park
Journal:  Oncol Lett       Date:  2011-09-28       Impact factor: 2.967

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.